IntroductionMost patients with HPV-positive oropharyngeal squamous cell carcinoma (OPSCC) have an excellent response to chemoradiation. and trials are now investigating de-escalated treatment. However. up to 25% of patients with HPV-positive OPSCC will experience recurrence. https://www.diegojavierfares.com/limited-save-1-64-Lowndes-2010-Triple-Eight-Race-Engineering-Suits-Holden-VE-Commodore-64168-special-save/